查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862377

Propofol药物：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Propofol Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球Propofol市场规模估计为 14 亿美元，预计到 2031 年将成长至 17.64 亿美元，在预测期（2025-2031 年）内复合年增长率为 3.6%。

本报告对近期Propofol药品的关税调整和国际策略反制措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组。

2024年，Propofol的全球产量约为3.76亿单位，全球平均市场价格约为每单位3.7美元。Propofol是一种短效静脉麻醉剂，用于诱导和维持全身麻醉、人工呼吸器成人病患的镇静、手术镇静。Propofol具有快速起效、恢復快速、功能恢復完全、术后噁心呕吐等副作用发生率低等优点。

需求增加：

由于慢性疾病、手术和医疗程序的增加，Propofol的需求正在增加。人口老化、生活方式的改变以及新兴市场医疗基础设施的不断改善，也促进了Propofol的成长。

技术进步：

药物输送系统和监测技术的进步扩大了Propofol的应用范围。标靶输注（TCI）系统等创新技术可实现更精确的给药，进而提高安全性和有效性。

拓展应用范围：

除了传统的外科手术和诊断程序外，Propofol的应用范围正在不断扩大，包括儿童麻醉、兽医学，甚至在治疗某些精神疾病（如难治性忧郁症）方面也有仿单标示外使用。

竞争加剧：

预计未来几年製造商之间的竞争将加剧，Propofol的替代品有望争夺更大的市场份额。

本报告旨在按地区/国家、类型和应用对全球Propofol药物市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

Propofol药物市场规模、估算和预测以销售（百万）和收入（百万美元）为单位呈现，以2024年为基准年，并包含2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定Propofol药物的业务和成长策略，评估竞争格局，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Fresenius Kabi
  • Aspen Pharma
  • B. Braun
  • Pfizer
  • Dr. Reddy's Laboratories
  • Rusoma
  • Centurion Healthcare
  • Wellona Pharma
  • NEON
  • Flagship Biotech
  • Xi'an Libang Pharmaceutical
  • Guangdong Jiabo Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Beijing Sciecure Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Jiangsu Yingke Biopharmaceutical

按类型分類的细分市场

  • 10 mL
  • 20 mL
  • 50 mL
  • 100 mL

应用领域

  • 全身麻醉
  • 医疗过程中的镇静
  • 人工呼吸
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Propofol Drug was estimated to be worth US$ 1400 million in 2024 and is forecast to a readjusted size of US$ 1764 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Propofol Drug cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global propofol drug production reached approximately 376 million units, with an average global market price of around US$ 3.7 per unit. Propofol drug is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting.

Increasing Demand:

The demand for propofol is increasing, driven by the rising incidence of chronic diseases, surgeries, and medical procedures. The aging population, changing lifestyles, and growing healthcare infrastructure in emerging markets are also contributing to the increasing demand for propofol.

Technological Advancements:

Advances in drug delivery systems and monitoring technologies are enhancing the use of propofol. Innovations such as target-controlled infusion (TCI) systems allow for more precise administration, improving safety and efficacy.

Expanding Applications:

Beyond traditional surgical and diagnostic procedures, propofol's applications are expanding into areas such as pediatric anesthesia, veterinary medicine, and even in treating certain psychiatric disorders like refractory depression through off-label use.

Intensified Competition:

Competition among manufacturers will intensify further in the coming years. In addition, propofol substitutes will try to occupy more market share.

This report aims to provide a comprehensive presentation of the global market for Propofol Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Propofol Drug by region & country, by Type, and by Application.

The Propofol Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propofol Drug.

Market Segmentation

By Company

  • Fresenius Kabi
  • Aspen Pharma
  • B. Braun
  • Pfizer
  • Dr. Reddy's Laboratories
  • Rusoma
  • Centurion Healthcare
  • Wellona Pharma
  • NEON
  • Flagship Biotech
  • Xi'an Libang Pharmaceutical
  • Guangdong Jiabo Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Beijing Sciecure Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Jiangsu Yingke Biopharmaceutical

Segment by Type

  • 10 mL
  • 20 mL
  • 50 mL
  • 100 mL

Segment by Application

  • General Anesthesia
  • Medical Procedures Sedation
  • Mechanical Ventilation
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Propofol Drug in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Propofol Drug Product Introduction
  • 1.2 Global Propofol Drug Market Size Forecast
    • 1.2.1 Global Propofol Drug Sales Value (2020-2031)
    • 1.2.2 Global Propofol Drug Sales Volume (2020-2031)
    • 1.2.3 Global Propofol Drug Sales Price (2020-2031)
  • 1.3 Propofol Drug Market Trends & Drivers
    • 1.3.1 Propofol Drug Industry Trends
    • 1.3.2 Propofol Drug Market Drivers & Opportunity
    • 1.3.3 Propofol Drug Market Challenges
    • 1.3.4 Propofol Drug Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Propofol Drug Players Revenue Ranking (2024)
  • 2.2 Global Propofol Drug Revenue by Company (2020-2025)
  • 2.3 Global Propofol Drug Players Sales Volume Ranking (2024)
  • 2.4 Global Propofol Drug Sales Volume by Company Players (2020-2025)
  • 2.5 Global Propofol Drug Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Propofol Drug Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Propofol Drug Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Propofol Drug
  • 2.9 Propofol Drug Market Competitive Analysis
    • 2.9.1 Propofol Drug Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Propofol Drug Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propofol Drug as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 10 mL
    • 3.1.2 20 mL
    • 3.1.3 50 mL
    • 3.1.4 100 mL
  • 3.2 Global Propofol Drug Sales Value by Type
    • 3.2.1 Global Propofol Drug Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Propofol Drug Sales Value, by Type (2020-2031)
    • 3.2.3 Global Propofol Drug Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Propofol Drug Sales Volume by Type
    • 3.3.1 Global Propofol Drug Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Propofol Drug Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Propofol Drug Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Propofol Drug Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 General Anesthesia
    • 4.1.2 Medical Procedures Sedation
    • 4.1.3 Mechanical Ventilation
    • 4.1.4 Other
  • 4.2 Global Propofol Drug Sales Value by Application
    • 4.2.1 Global Propofol Drug Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Propofol Drug Sales Value, by Application (2020-2031)
    • 4.2.3 Global Propofol Drug Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Propofol Drug Sales Volume by Application
    • 4.3.1 Global Propofol Drug Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Propofol Drug Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Propofol Drug Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Propofol Drug Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Propofol Drug Sales Value by Region
    • 5.1.1 Global Propofol Drug Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Propofol Drug Sales Value by Region (2020-2025)
    • 5.1.3 Global Propofol Drug Sales Value by Region (2026-2031)
    • 5.1.4 Global Propofol Drug Sales Value by Region (%), (2020-2031)
  • 5.2 Global Propofol Drug Sales Volume by Region
    • 5.2.1 Global Propofol Drug Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Propofol Drug Sales Volume by Region (2020-2025)
    • 5.2.3 Global Propofol Drug Sales Volume by Region (2026-2031)
    • 5.2.4 Global Propofol Drug Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Propofol Drug Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Propofol Drug Sales Value, 2020-2031
    • 5.4.2 North America Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Propofol Drug Sales Value, 2020-2031
    • 5.5.2 Europe Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Propofol Drug Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Propofol Drug Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Propofol Drug Sales Value, 2020-2031
    • 5.7.2 South America Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Propofol Drug Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Propofol Drug Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Propofol Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Propofol Drug Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Propofol Drug Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Propofol Drug Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Propofol Drug Sales Value, 2020-2031
    • 6.3.2 United States Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Propofol Drug Sales Value, 2020-2031
    • 6.4.2 Europe Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Propofol Drug Sales Value, 2020-2031
    • 6.5.2 China Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Propofol Drug Sales Value, 2020-2031
    • 6.6.2 Japan Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Propofol Drug Sales Value, 2020-2031
    • 6.7.2 South Korea Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Propofol Drug Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Propofol Drug Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Propofol Drug Sales Value, 2020-2031
    • 6.9.2 India Propofol Drug Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Propofol Drug Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Fresenius Kabi
    • 7.1.1 Fresenius Kabi Company Information
    • 7.1.2 Fresenius Kabi Introduction and Business Overview
    • 7.1.3 Fresenius Kabi Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Fresenius Kabi Propofol Drug Product Offerings
    • 7.1.5 Fresenius Kabi Recent Development
  • 7.2 Aspen Pharma
    • 7.2.1 Aspen Pharma Company Information
    • 7.2.2 Aspen Pharma Introduction and Business Overview
    • 7.2.3 Aspen Pharma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Aspen Pharma Propofol Drug Product Offerings
    • 7.2.5 Aspen Pharma Recent Development
  • 7.3 B. Braun
    • 7.3.1 B. Braun Company Information
    • 7.3.2 B. Braun Introduction and Business Overview
    • 7.3.3 B. Braun Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 B. Braun Propofol Drug Product Offerings
    • 7.3.5 B. Braun Recent Development
  • 7.4 Pfizer
    • 7.4.1 Pfizer Company Information
    • 7.4.2 Pfizer Introduction and Business Overview
    • 7.4.3 Pfizer Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Pfizer Propofol Drug Product Offerings
    • 7.4.5 Pfizer Recent Development
  • 7.5 Dr. Reddy's Laboratories
    • 7.5.1 Dr. Reddy's Laboratories Company Information
    • 7.5.2 Dr. Reddy's Laboratories Introduction and Business Overview
    • 7.5.3 Dr. Reddy's Laboratories Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Dr. Reddy's Laboratories Propofol Drug Product Offerings
    • 7.5.5 Dr. Reddy's Laboratories Recent Development
  • 7.6 Rusoma
    • 7.6.1 Rusoma Company Information
    • 7.6.2 Rusoma Introduction and Business Overview
    • 7.6.3 Rusoma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Rusoma Propofol Drug Product Offerings
    • 7.6.5 Rusoma Recent Development
  • 7.7 Centurion Healthcare
    • 7.7.1 Centurion Healthcare Company Information
    • 7.7.2 Centurion Healthcare Introduction and Business Overview
    • 7.7.3 Centurion Healthcare Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Centurion Healthcare Propofol Drug Product Offerings
    • 7.7.5 Centurion Healthcare Recent Development
  • 7.8 Wellona Pharma
    • 7.8.1 Wellona Pharma Company Information
    • 7.8.2 Wellona Pharma Introduction and Business Overview
    • 7.8.3 Wellona Pharma Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Wellona Pharma Propofol Drug Product Offerings
    • 7.8.5 Wellona Pharma Recent Development
  • 7.9 NEON
    • 7.9.1 NEON Company Information
    • 7.9.2 NEON Introduction and Business Overview
    • 7.9.3 NEON Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 NEON Propofol Drug Product Offerings
    • 7.9.5 NEON Recent Development
  • 7.10 Flagship Biotech
    • 7.10.1 Flagship Biotech Company Information
    • 7.10.2 Flagship Biotech Introduction and Business Overview
    • 7.10.3 Flagship Biotech Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Flagship Biotech Propofol Drug Product Offerings
    • 7.10.5 Flagship Biotech Recent Development
  • 7.11 Xi'an Libang Pharmaceutical
    • 7.11.1 Xi'an Libang Pharmaceutical Company Information
    • 7.11.2 Xi'an Libang Pharmaceutical Introduction and Business Overview
    • 7.11.3 Xi'an Libang Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Xi'an Libang Pharmaceutical Propofol Drug Product Offerings
    • 7.11.5 Xi'an Libang Pharmaceutical Recent Development
  • 7.12 Guangdong Jiabo Pharmaceutical
    • 7.12.1 Guangdong Jiabo Pharmaceutical Company Information
    • 7.12.2 Guangdong Jiabo Pharmaceutical Introduction and Business Overview
    • 7.12.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Offerings
    • 7.12.5 Guangdong Jiabo Pharmaceutical Recent Development
  • 7.13 Sichuan Biokin Pharmaceutical
    • 7.13.1 Sichuan Biokin Pharmaceutical Company Information
    • 7.13.2 Sichuan Biokin Pharmaceutical Introduction and Business Overview
    • 7.13.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Offerings
    • 7.13.5 Sichuan Biokin Pharmaceutical Recent Development
  • 7.14 Sichuan Kelun Pharmaceutical
    • 7.14.1 Sichuan Kelun Pharmaceutical Company Information
    • 7.14.2 Sichuan Kelun Pharmaceutical Introduction and Business Overview
    • 7.14.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Offerings
    • 7.14.5 Sichuan Kelun Pharmaceutical Recent Development
  • 7.15 Beijing Sciecure Pharmaceutical
    • 7.15.1 Beijing Sciecure Pharmaceutical Company Information
    • 7.15.2 Beijing Sciecure Pharmaceutical Introduction and Business Overview
    • 7.15.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Offerings
    • 7.15.5 Beijing Sciecure Pharmaceutical Recent Development
  • 7.16 Jiangsu Nhwa Pharmaceutical
    • 7.16.1 Jiangsu Nhwa Pharmaceutical Company Information
    • 7.16.2 Jiangsu Nhwa Pharmaceutical Introduction and Business Overview
    • 7.16.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Offerings
    • 7.16.5 Jiangsu Nhwa Pharmaceutical Recent Development
  • 7.17 Jiangsu Yingke Biopharmaceutical
    • 7.17.1 Jiangsu Yingke Biopharmaceutical Company Information
    • 7.17.2 Jiangsu Yingke Biopharmaceutical Introduction and Business Overview
    • 7.17.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Offerings
    • 7.17.5 Jiangsu Yingke Biopharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Propofol Drug Industrial Chain
  • 8.2 Propofol Drug Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Propofol Drug Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Propofol Drug Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Propofol Drug Market Trends
  • Table 2. Propofol Drug Market Drivers & Opportunity
  • Table 3. Propofol Drug Market Challenges
  • Table 4. Propofol Drug Market Restraints
  • Table 5. Global Propofol Drug Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Propofol Drug Revenue Market Share by Company (2020-2025)
  • Table 7. Global Propofol Drug Sales Volume by Company (2020-2025) & (M Units)
  • Table 8. Global Propofol Drug Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Propofol Drug Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Propofol Drug Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Propofol Drug Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Propofol Drug
  • Table 13. Global Propofol Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Propofol Drug as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Propofol Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Propofol Drug Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Propofol Drug Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Propofol Drug Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Propofol Drug Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Propofol Drug Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)
  • Table 22. Global Propofol Drug Sales Volume by Type (2020-2025) & (M Units)
  • Table 23. Global Propofol Drug Sales Volume by Type (2026-2031) & (M Units)
  • Table 24. Global Propofol Drug Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Propofol Drug Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Propofol Drug Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Propofol Drug Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Propofol Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Propofol Drug Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Propofol Drug Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Propofol Drug Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Propofol Drug Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Propofol Drug Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)
  • Table 34. Global Propofol Drug Sales Volume by Application (2020-2025) & (M Units)
  • Table 35. Global Propofol Drug Sales Volume by Application (2026-2031) & (M Units)
  • Table 36. Global Propofol Drug Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Propofol Drug Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Propofol Drug Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Propofol Drug Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Propofol Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Propofol Drug Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Propofol Drug Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Propofol Drug Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Propofol Drug Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Propofol Drug Sales Volume by Region (M Units): 2020 VS 2024 VS 2031
  • Table 46. Global Propofol Drug Sales Volume by Region (2020-2025) & (M Units)
  • Table 47. Global Propofol Drug Sales Volume by Region (2026-2031) & (M Units)
  • Table 48. Global Propofol Drug Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Propofol Drug Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Propofol Drug Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Propofol Drug Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Propofol Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Propofol Drug Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Propofol Drug Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Propofol Drug Sales Volume, (2020-2025) & (M Units)
  • Table 56. Key Countries/Regions Propofol Drug Sales Volume, (2026-2031) & (M Units)
  • Table 57. Fresenius Kabi Company Information
  • Table 58. Fresenius Kabi Introduction and Business Overview
  • Table 59. Fresenius Kabi Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Fresenius Kabi Propofol Drug Product Offerings
  • Table 61. Fresenius Kabi Recent Development
  • Table 62. Aspen Pharma Company Information
  • Table 63. Aspen Pharma Introduction and Business Overview
  • Table 64. Aspen Pharma Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Aspen Pharma Propofol Drug Product Offerings
  • Table 66. Aspen Pharma Recent Development
  • Table 67. B. Braun Company Information
  • Table 68. B. Braun Introduction and Business Overview
  • Table 69. B. Braun Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. B. Braun Propofol Drug Product Offerings
  • Table 71. B. Braun Recent Development
  • Table 72. Pfizer Company Information
  • Table 73. Pfizer Introduction and Business Overview
  • Table 74. Pfizer Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Pfizer Propofol Drug Product Offerings
  • Table 76. Pfizer Recent Development
  • Table 77. Dr. Reddy's Laboratories Company Information
  • Table 78. Dr. Reddy's Laboratories Introduction and Business Overview
  • Table 79. Dr. Reddy's Laboratories Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Dr. Reddy's Laboratories Propofol Drug Product Offerings
  • Table 81. Dr. Reddy's Laboratories Recent Development
  • Table 82. Rusoma Company Information
  • Table 83. Rusoma Introduction and Business Overview
  • Table 84. Rusoma Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Rusoma Propofol Drug Product Offerings
  • Table 86. Rusoma Recent Development
  • Table 87. Centurion Healthcare Company Information
  • Table 88. Centurion Healthcare Introduction and Business Overview
  • Table 89. Centurion Healthcare Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Centurion Healthcare Propofol Drug Product Offerings
  • Table 91. Centurion Healthcare Recent Development
  • Table 92. Wellona Pharma Company Information
  • Table 93. Wellona Pharma Introduction and Business Overview
  • Table 94. Wellona Pharma Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Wellona Pharma Propofol Drug Product Offerings
  • Table 96. Wellona Pharma Recent Development
  • Table 97. NEON Company Information
  • Table 98. NEON Introduction and Business Overview
  • Table 99. NEON Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. NEON Propofol Drug Product Offerings
  • Table 101. NEON Recent Development
  • Table 102. Flagship Biotech Company Information
  • Table 103. Flagship Biotech Introduction and Business Overview
  • Table 104. Flagship Biotech Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. Flagship Biotech Propofol Drug Product Offerings
  • Table 106. Flagship Biotech Recent Development
  • Table 107. Xi'an Libang Pharmaceutical Company Information
  • Table 108. Xi'an Libang Pharmaceutical Introduction and Business Overview
  • Table 109. Xi'an Libang Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. Xi'an Libang Pharmaceutical Propofol Drug Product Offerings
  • Table 111. Xi'an Libang Pharmaceutical Recent Development
  • Table 112. Guangdong Jiabo Pharmaceutical Company Information
  • Table 113. Guangdong Jiabo Pharmaceutical Introduction and Business Overview
  • Table 114. Guangdong Jiabo Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Guangdong Jiabo Pharmaceutical Propofol Drug Product Offerings
  • Table 116. Guangdong Jiabo Pharmaceutical Recent Development
  • Table 117. Sichuan Biokin Pharmaceutical Company Information
  • Table 118. Sichuan Biokin Pharmaceutical Introduction and Business Overview
  • Table 119. Sichuan Biokin Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Sichuan Biokin Pharmaceutical Propofol Drug Product Offerings
  • Table 121. Sichuan Biokin Pharmaceutical Recent Development
  • Table 122. Sichuan Kelun Pharmaceutical Company Information
  • Table 123. Sichuan Kelun Pharmaceutical Introduction and Business Overview
  • Table 124. Sichuan Kelun Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. Sichuan Kelun Pharmaceutical Propofol Drug Product Offerings
  • Table 126. Sichuan Kelun Pharmaceutical Recent Development
  • Table 127. Beijing Sciecure Pharmaceutical Company Information
  • Table 128. Beijing Sciecure Pharmaceutical Introduction and Business Overview
  • Table 129. Beijing Sciecure Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 130. Beijing Sciecure Pharmaceutical Propofol Drug Product Offerings
  • Table 131. Beijing Sciecure Pharmaceutical Recent Development
  • Table 132. Jiangsu Nhwa Pharmaceutical Company Information
  • Table 133. Jiangsu Nhwa Pharmaceutical Introduction and Business Overview
  • Table 134. Jiangsu Nhwa Pharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 135. Jiangsu Nhwa Pharmaceutical Propofol Drug Product Offerings
  • Table 136. Jiangsu Nhwa Pharmaceutical Recent Development
  • Table 137. Jiangsu Yingke Biopharmaceutical Company Information
  • Table 138. Jiangsu Yingke Biopharmaceutical Introduction and Business Overview
  • Table 139. Jiangsu Yingke Biopharmaceutical Propofol Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 140. Jiangsu Yingke Biopharmaceutical Propofol Drug Product Offerings
  • Table 141. Jiangsu Yingke Biopharmaceutical Recent Development
  • Table 142. Key Raw Materials Lists
  • Table 143. Raw Materials Key Suppliers Lists
  • Table 144. Propofol Drug Downstream Customers
  • Table 145. Propofol Drug Distributors List
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Propofol Drug Product Picture
  • Figure 2. Global Propofol Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Propofol Drug Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Propofol Drug Sales Volume (2020-2031) & (M Units)
  • Figure 5. Global Propofol Drug Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Propofol Drug Report Years Considered
  • Figure 7. Global Propofol Drug Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Propofol Drug Players Sales Volume Ranking (2024) & (M Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Propofol Drug Revenue in 2024
  • Figure 10. Propofol Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. 10 mL Picture
  • Figure 12. 20 mL Picture
  • Figure 13. 50 mL Picture
  • Figure 14. 100 mL Picture
  • Figure 15. Global Propofol Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Propofol Drug Sales Value Market Share by Type, 2024 & 2031
  • Figure 17. Global Propofol Drug Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)
  • Figure 18. Global Propofol Drug Sales Volume Market Share by Type, 2024 & 2031
  • Figure 19. Global Propofol Drug Price by Type (2020-2031) & (US$/Unit)
  • Figure 20. Product Picture of General Anesthesia
  • Figure 21. Product Picture of Medical Procedures Sedation
  • Figure 22. Product Picture of Mechanical Ventilation
  • Figure 23. Product Picture of Other
  • Figure 24. Global Propofol Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 25. Global Propofol Drug Sales Value Market Share by Application, 2024 & 2031
  • Figure 26. Global Propofol Drug Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)
  • Figure 27. Global Propofol Drug Sales Volume Market Share by Application, 2024 & 2031
  • Figure 28. Global Propofol Drug Price by Application (2020-2031) & (US$/Unit)
  • Figure 29. North America Propofol Drug Sales Value (2020-2031) & (US$ Million)
  • Figure 30. North America Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Europe Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Asia Pacific Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Asia Pacific Propofol Drug Sales Value by Region (%), 2024 VS 2031
  • Figure 35. South America Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. South America Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Middle East & Africa Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Middle East & Africa Propofol Drug Sales Value by Country (%), 2024 VS 2031
  • Figure 39. Key Countries/Regions Propofol Drug Sales Value (%), (2020-2031)
  • Figure 40. Key Countries/Regions Propofol Drug Sales Volume (%), (2020-2031)
  • Figure 41. United States Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. United States Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 43. United States Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Europe Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Europe Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Europe Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 47. China Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. China Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 49. China Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Japan Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Japan Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Japan Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 53. South Korea Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. South Korea Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 55. South Korea Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 56. Southeast Asia Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. Southeast Asia Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 58. Southeast Asia Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 59. India Propofol Drug Sales Value, (2020-2031) & (US$ Million)
  • Figure 60. India Propofol Drug Sales Value by Type (%), 2024 VS 2031
  • Figure 61. India Propofol Drug Sales Value by Application (%), 2024 VS 2031
  • Figure 62. Propofol Drug Industrial Chain
  • Figure 63. Propofol Drug Manufacturing Cost Structure
  • Figure 64. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed